News Release: SOLD | 3801 Chestnut Street | 310,000 SF Lab Development

NEWMARK
HEALTHCARE CAPITAL MARKETS

CLOSING ANNOUNCEMENT

310,000 SF Lab Development

3801 Chestnut Street
University City | Philadelphia, PA

MARCH 2022

Newmark is pleased to announce the sale of 3801 Chestnut Street, a to-be-built 310,000 SF life science development site in the University City neighborhood of Philadelphia, a leading center of science, innovation, research and education.

uCity is home to one of the leading concentrations of health systems, teaching hospitals, research institutions and biotechnology firms in the nation. The property is immediately surrounded by such institutions as The University of Pennsylvania, Penn Medicine, Children’s Hospital of Philadelphia, Drexel University and The Wistar Institute.

FOR ADDITIONAL INFORMATION ON THIS TRANSACTION AND THE CURRENT CAPITAL MARKET ENVIRONMENT, PLEASE CONTACT ANY MEMBER OF THE TRANSACTION ADVISORY TEAM.

HEALTHCARE CAPITAL MARKETS

Ben Appel
Eveculiue Managing Direclor
215.872.9903
ben.appel@nmrk.com

Jim Tribble
Evecutive Managing Direclor
617.863.8607
jim.tribble@nmrk.com

Michael Greeley
Senior Managing Di
617223.1623michael.greeley@nmrk.com

Jay Miele
Managing Director
732.778.3895
jay.miele@nmrk.com

John Nero
Managing I)imclor
610.308.8192
john.nero@nmrk.com

HEALTHCARE LEASING

Sid Smith
Executive Managing Director
215.320.4511
sid.smith@nmrk.com

James A. Egan
Eveculive Managing Director
215.246.2750
james.egan@nmrk.com

Neil Brazitis
Senior Managing Direclor
215.320.4522
neil.brazitis@nmrk.com

HEALTHCARE CAPITAL MARKETS ANALYTICS

Ron Ott
Associate
570.417.8140
ron.ott@nmrk.com

Adam Goss
Associate
713.444.1024
adam.goss@nmrk.com

Newmark Healthcare Capital Markets

The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In